# Motorsport Games Inc.: financial statements, quarterly

MSGM · Nasdaq · CIK 1821175 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/msgm.md) · [Financials](/companies/msgm/financials.md) · [Filings](/companies/msgm/filings.md) · [Insiders](/companies/msgm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/msgm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,694](/filings/0001493152-24-045867.md) | [1,747 d](/filings/0001493152-25-011033.md) | [3,029](/filings/0001641172-25-009451.md) | [1,882](/filings/0001493152-25-011905.md) | [1,803](/filings/0001493152-25-021071.md) | [1,974 d](/filings/0001493152-26-009532.md) | [1,758](/filings/0001493152-26-022725.md) | [2,592](/filings/0001493152-26-038360.md) | [3,100](/filings/0001493152-25-021071.md) | [3,848 d](/filings/0001493152-26-009532.md) | [4,031](/filings/0001493152-26-022725.md) | [3,540](/filings/0001493152-26-038360.md) |
| Cost of revenue | $k | [831](/filings/0001493152-24-045867.md) | [674 d](/filings/0001493152-25-011033.md) | [667](/filings/0001641172-25-009451.md) | [772](/filings/0001493152-25-011905.md) | [717](/filings/0001493152-25-021071.md) | [1,071 d](/filings/0001493152-26-009532.md) | [465](/filings/0001493152-26-022725.md) | [455](/filings/0001493152-26-038360.md) | [598](/filings/0001493152-25-021071.md) | [575 d](/filings/0001493152-26-009532.md) | [517](/filings/0001493152-26-022725.md) | [644](/filings/0001493152-26-038360.md) |
| Gross profit | $k | [862](/filings/0001493152-24-045867.md) | [1,073 d](/filings/0001493152-25-011033.md) | [2,362](/filings/0001641172-25-009451.md) | [1,110](/filings/0001493152-25-011905.md) | [1,086](/filings/0001493152-25-021071.md) | [903 d](/filings/0001493152-26-009532.md) | [1,293](/filings/0001493152-26-022725.md) | [2,137](/filings/0001493152-26-038360.md) | [2,502](/filings/0001493152-25-021071.md) | [3,272 d](/filings/0001493152-26-009532.md) | [3,514](/filings/0001493152-26-022725.md) | [2,896](/filings/0001493152-26-038360.md) |
| Research and development | $k | [1,567](/filings/0001493152-24-045867.md) | [1,485 d](/filings/0001493152-25-011033.md) | [1,063](/filings/0001641172-25-009451.md) | [869](/filings/0001493152-25-011905.md) | [849](/filings/0001493152-25-021071.md) | [598 d](/filings/0001493152-26-009532.md) | [602](/filings/0001493152-26-022725.md) | [270](/filings/0001493152-26-038360.md) | [419](/filings/0001493152-25-021071.md) | [469 d](/filings/0001493152-26-009532.md) | [514](/filings/0001493152-26-022725.md) | [737](/filings/0001493152-26-038360.md) |
| Operating income | $k | [(2,665)](/filings/0001493152-24-045867.md) | [318 d](/filings/0001493152-25-011033.md) | [(1,215)](/filings/0001641172-25-009451.md) | [2,059](/filings/0001493152-25-011905.md) | [(1,932)](/filings/0001493152-25-021071.md) | [(661) d](/filings/0001493152-26-009532.md) | [(93.2)](/filings/0001493152-26-022725.md) | [1,968](/filings/0001493152-26-038360.md) | [799](/filings/0001493152-25-021071.md) | [575 d](/filings/0001493152-26-009532.md) | [1,056](/filings/0001493152-26-022725.md) | [638](/filings/0001493152-26-038360.md) |
| Interest expense | $k | [230](/filings/0001493152-24-045867.md) | [98.9 d](/filings/0001493152-25-011033.md) | [30.9](/filings/0001641172-25-009451.md) | [29.7](/filings/0001493152-25-011905.md) | [29.9](/filings/0001493152-25-021071.md) | [30.3 d](/filings/0001493152-26-009532.md) | [13.0](/filings/0001493152-26-022725.md) | [4.7](/filings/0001493152-26-038360.md) | [1.4](/filings/0001493152-25-021071.md) | [(0.4) d](/filings/0001493152-26-009532.md) | [3.2](/filings/0001493152-26-022725.md) | [15.9](/filings/0001493152-26-038360.md) |
| Net income | $k | [(3,564)](/filings/0001493152-24-045867.md) | [2,769 d](/filings/0001493152-25-011033.md) | [(1,665)](/filings/0001641172-25-009451.md) | [2,106](/filings/0001493152-25-011905.md) | [(555)](/filings/0001493152-25-021071.md) | [(2,639) d](/filings/0001493152-26-009532.md) | [1,041](/filings/0001493152-26-022725.md) | [4,258](/filings/0001493152-26-038360.md) | [789](/filings/0001493152-25-021071.md) | [839 d](/filings/0001493152-26-009532.md) | [316](/filings/0001493152-26-022725.md) | [401](/filings/0001493152-26-038360.md) |
| Diluted EPS | $ per share | [(1.31)](/filings/0001493152-24-045867.md) | not reported | [(0.61)](/filings/0001641172-25-009451.md) | [0.77](/filings/0001493152-25-011905.md) | [(0.18)](/filings/0001493152-25-021071.md) | not reported | [0.33](/filings/0001493152-26-022725.md) | [0.82](/filings/0001493152-26-038360.md) | [0.14](/filings/0001493152-25-021071.md) | not reported | [0.06](/filings/0001493152-26-022725.md) | [0.08](/filings/0001493152-26-038360.md) |
| Basic EPS | $ per share | [(1.31)](/filings/0001493152-24-045867.md) | not reported | [(0.61)](/filings/0001641172-25-009451.md) | [0.77](/filings/0001493152-25-011905.md) | [(0.18)](/filings/0001493152-25-021071.md) | not reported | [0.33](/filings/0001493152-26-022725.md) | [0.82](/filings/0001493152-26-038360.md) | [0.14](/filings/0001493152-25-021071.md) | not reported | [0.06](/filings/0001493152-26-022725.md) | [0.08](/filings/0001493152-26-038360.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.2](/filings/0001493152-23-039752.md) | [1.7](/filings/0001493152-25-011033.md) | [0.5](/filings/0001641172-25-009451.md) | [0.3](/filings/0001493152-25-011905.md) | [1.1](/filings/0001493152-25-021071.md) | [0.9](/filings/0001493152-26-009532.md) | [1.1](/filings/0001641172-25-009451.md) | [2.4](/filings/0001493152-25-011905.md) | [4.1](/filings/0001493152-25-021071.md) | [5.0](/filings/0001493152-26-038360.md) | [5.9](/filings/0001493152-26-022725.md) | [3.9](/filings/0001493152-26-038360.md) |
| Current assets | $m | [2.8](/filings/0001493152-23-039752.md) | [3.5](/filings/0001493152-25-011033.md) | [4.2](/filings/0001493152-24-018097.md) | [2.2](/filings/0001493152-24-030976.md) | [2.4](/filings/0001493152-24-045867.md) | [2.8](/filings/0001493152-26-009532.md) | [2.7](/filings/0001641172-25-009451.md) | [4.8](/filings/0001493152-25-011905.md) | [6.3](/filings/0001493152-25-021071.md) | [7.6](/filings/0001493152-26-038360.md) | [9.1](/filings/0001493152-26-022725.md) | [6.4](/filings/0001493152-26-038360.md) |
| Total assets | $m | [11.4](/filings/0001493152-23-039752.md) | [9.8](/filings/0001493152-25-011033.md) | [9.8](/filings/0001493152-24-018097.md) | [7.2](/filings/0001493152-24-030976.md) | [7.0](/filings/0001493152-24-045867.md) | [6.3](/filings/0001493152-26-009532.md) | [6.1](/filings/0001641172-25-009451.md) | [8.2](/filings/0001493152-25-011905.md) | [10.1](/filings/0001493152-25-021071.md) | [12.0](/filings/0001493152-26-038360.md) | [13.9](/filings/0001493152-26-022725.md) | [11.3](/filings/0001493152-26-038360.md) |
| Current liabilities | $m | [8.0](/filings/0001493152-23-039752.md) | [7.6](/filings/0001493152-25-011033.md) | [8.8](/filings/0001493152-24-018097.md) | [4.1](/filings/0001493152-24-030976.md) | [4.8](/filings/0001493152-24-045867.md) | [5.0](/filings/0001493152-26-009532.md) | [4.6](/filings/0001641172-25-009451.md) | [2.6](/filings/0001493152-25-011905.md) | [3.3](/filings/0001493152-25-021071.md) | [3.4](/filings/0001493152-26-038360.md) | [3.9](/filings/0001493152-26-022725.md) | [3.5](/filings/0001493152-26-038360.md) |
| Total liabilities | $m | [10.9](/filings/0001493152-23-039752.md) | [7.7](/filings/0001493152-25-011033.md) | [8.8](/filings/0001493152-24-018097.md) | [4.2](/filings/0001493152-24-030976.md) | [4.8](/filings/0001493152-24-045867.md) | [5.0](/filings/0001493152-26-009532.md) | [4.6](/filings/0001641172-25-009451.md) | [2.6](/filings/0001493152-25-011905.md) | [3.3](/filings/0001493152-25-021071.md) | [4.4](/filings/0001493152-26-038360.md) | [5.3](/filings/0001493152-26-022725.md) | [6.1](/filings/0001493152-26-038360.md) |
| Shareholders' equity | $m | [0.4](/filings/0001493152-23-039752.md) | [1.0](/filings/0001493152-25-011033.md) | [2.1](/filings/0001493152-24-018097.md) | [4.3](/filings/0001493152-24-030976.md) | [4.1](/filings/0001493152-24-045867.md) | [0.5](/filings/0001493152-26-009532.md) | [0.6](/filings/0001641172-25-009451.md) | [4.8](/filings/0001493152-25-011905.md) | [5.9](/filings/0001493152-25-021071.md) | [6.8](/filings/0001493152-26-038360.md) | [7.1](/filings/0001493152-26-022725.md) | [3.9](/filings/0001493152-26-038360.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,256) d](/filings/0001493152-24-045867.md) | [(3,546) d](/filings/0001493152-25-011033.md) | [(374)](/filings/0001641172-25-009451.md) | [(696) d](/filings/0001493152-25-011905.md) | [(680) d](/filings/0001493152-25-021071.md) | [(1,088) d](/filings/0001493152-26-009532.md) | [377](/filings/0001493152-26-022725.md) | [232 d](/filings/0001493152-26-038360.md) | [1,724 d](/filings/0001493152-25-021071.md) | [1,741 d](/filings/0001493152-26-009532.md) | [1,650](/filings/0001493152-26-022725.md) | [1,122 d](/filings/0001493152-26-038360.md) |
| Capital expenditure | $k | [2.4 d](/filings/0001493152-24-045867.md) | [4.9 d](/filings/0001493152-25-011033.md) | not reported | not reported | [0.0 d](/filings/0001493152-25-021071.md) | [(0.1) d](/filings/0001493152-26-009532.md) | not reported | not reported | not reported | [8.2 d](/filings/0001493152-26-009532.md) | [21.6](/filings/0001493152-26-022725.md) | [7.7 d](/filings/0001493152-26-038360.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [1,167](/filings/0001493152-23-039752.md) | [2,192](/filings/0001493152-24-018097.md) | [2,704](/filings/0001493152-24-030976.md) | [2,720](/filings/0001493152-24-045867.md) | [2,723](/filings/0001641172-25-009451.md) | [2,723](/filings/0001493152-25-011905.md) | [3,024](/filings/0001493152-25-021071.md) | [3,184](/filings/0001493152-26-022725.md) | [5,207](/filings/0001493152-26-038360.md) | [5,456](/filings/0001493152-25-021071.md) | [5,482](/filings/0001493152-26-022725.md) | [5,255](/filings/0001493152-26-038360.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.